Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial
about
Inflammation, Immune Activation, and Antiretroviral Therapy in HIVGut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.Strategies to limit immune-activation in HIV patients.Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients.Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals.Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.A protocol for quantizing total bacterial 16S rDNA in plasma as a marker of microbial translocation in vivo.
P2860
Q33912595-C86F2EC1-FF4A-4405-9638-0B3616802A69Q36132003-FFE25025-CD8F-4566-819A-68FAE09151D3Q36988081-0513AB5C-C5E4-4AB4-9908-B7F934C44821Q38985926-81A9D500-3028-4235-8F78-9A5276BFA170Q39030604-571CE68A-05F3-4D38-977F-8F39FB008FE3Q39366403-0942CB69-E759-4AEF-8CFD-604EF4AF29F8Q40158843-AA2AA075-ECCF-441A-B115-E45D87092A71Q40531468-4B1380DE-0DB8-49FB-AD00-BA1BB46DE96EQ41926419-2CA2B747-5002-406A-92E1-EE1CE063CE5AQ41989387-1AC1F965-0CA4-404F-A3C4-8AC6E66798F3Q42355632-870F8771-39B5-4B95-AFB4-A3A06B56CF02Q42934696-CF9E5D0D-F25E-410D-966F-BB0FD45AE684Q52719203-1ACD5093-1D5A-4E1E-9E95-64B933556343
P2860
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@ast
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@en
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@nl
type
label
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@ast
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@en
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@nl
prefLabel
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@ast
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@en
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@nl
P2093
P2860
P50
P3181
P1433
P1476
Effects of Combined CCR5/Integ ...... rapy: A Pilot Randomized Trial
@en
P2093
Alan Landay
Angela D Kashuba
Anoma Somasunderam
Anthony Albanese
Basile Siewe
Christopher J Miller
David M Asmuth
Elizabeth Sinclair
Paolo Troia-Cancio
Richard B Pollard
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1005381
P407
P577
2016-01-01T00:00:00Z